Related Experiment Video
Updated: Jul 16, 2025

A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
rasa1-related arteriovenous malformation is driven by aberrant venous signalling
Jasper Greysson-Wong1,2, Rachael Rode1,3, Jae-Ryeon Ryu1,2
1Alberta Children's Hospital Research Institute, University of Calgary, 3330 University Drive NW, Calgary, AB T2N 4N1, Canada.
Mutations in RASA1 cause arteriovenous malformations (AVMs) by altering blood flow and vessel remodeling. Blocking MEK/ERK signaling in veins prevents AVM initiation in zebrafish, revealing a key mechanism.
Area of Science:
- Vascular biology
- Genetics
- Developmental biology
Background:
- Arteriovenous malformations (AVMs) result from abnormal endothelial signaling, creating direct artery-to-vein connections.
- Mutations in RASA1 are linked to human AVMs and are investigated here in a zebrafish model.
Purpose of the Study:
- To investigate the mechanisms underlying AVM development in rasa1 mutant zebrafish.
- To identify the molecular pathways involved in AVM initiation and progression.
Main Methods:
- Generation and analysis of rasa1 mutant zebrafish.
- Hemodynamic measurements in the aorta and caudal venous plexus (CVP).
- Gene expression analysis (klf2a) and pathway inhibition (MEK/ERK).
Main Results:
- Rasa1 mutants exhibit cavernous AVMs with altered blood flow dynamics and impaired CVP remodeling.
- Hemodynamic changes correlate with reduced klf2a expression.
- Ectopic MEK/ERK activation in veins drives AVM initiation, and its inhibition prevents AVM formation.
Conclusions:
- RASA1 mutations initiate AVMs through aberrant venous MEK/ERK signaling.
- MEK/ERK pathway modulation offers a potential therapeutic target for AVMs.
Related Concept Videos
Venous Thrombosis I: Introduction
Regulation of Angiogenesis and Blood Supply
Hemodialysis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins I: Introduction
Esophageal Varices-I: Introduction

